002907 华森制药
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资0--015,41421,94325,975
投资性房地产62,804-2.04%64,11268,32871,15718,970
固定资产458,334-3.66%475,744527,896567,397604,288
在建工程8,075-38.79%13,19210,19125,77617,516
无形资产195,600-6.59%209,393125,888107,13675,257
商誉0--0000
其他非流动资产150,87011.04%135,876138,488163,406167,711
875,684-2.52%898,317886,205956,815909,717

流动资产
货币资金299,1629.05%274,338456,553437,565503,529
应收账款262,12441.52%185,224174,843169,364216,844
存货121,055-12.93%139,028140,125151,677114,756
其他流动资产491,369-7.33%530,252259,824136,034121,821
1,173,7113.97%1,128,8421,031,345894,639956,949

流动负债
短期借款0--0000
应付票据0--0000
应付帐款70,5721.46%69,55664,36355,23348,043
其他流动负债181,720-6.76%194,885147,671133,445163,277
252,292-4.59%264,440212,034188,677211,320
流动资产净值921,4196.60%864,401819,310705,962745,630
资产总额减流动负债1,797,1021.95%1,762,7181,705,5151,662,7771,655,347

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债50,489-9.08%55,53145,51744,85644,957
50,489-9.08%55,53145,51744,85644,957

总权益
    实收股本417,5960.00%417,596417,596417,596417,596
    储备项目1,320,1823.65%1,273,7251,242,4021,200,3251,192,794
股东权益1,737,7782.75%1,691,3221,659,9981,617,9211,610,390
非控股权益8,835-44.31%15,865000